Innovative Medical Valuation
| 002173 Stock | 10.11 0.74 6.82% |
At this time, the firm appears to be overvalued. Innovative Medical retains a regular Real Value of USD9.0 per share. The prevalent price of the firm is USD10.11. Our model calculates the value of Innovative Medical from evaluating the firm fundamentals such as Return On Equity of -0.0256, current valuation of 3.98 B, and Return On Asset of -0.0147 as well as inspecting its technical indicators and probability of bankruptcy.
Price Book 2.4216 | Enterprise Value 4 B | Enterprise Value Ebitda (32.59) | Price Sales 5.3577 | Enterprise Value Revenue 4.9202 |
Overvalued
Today
Please note that Innovative Medical's price fluctuation is slightly risky at this time. Calculation of the real value of Innovative Medical is based on 3 months time horizon. Increasing Innovative Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Innovative Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Innovative Stock. However, Innovative Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.11 | Real 9.0 | Hype 9.8 | Naive 10.0 |
The real value of Innovative Stock, also known as its intrinsic value, is the underlying worth of Innovative Medical Company, which is reflected in its stock price. It is based on Innovative Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Innovative Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Innovative Medical Management helps investors to forecast how Innovative stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Innovative Medical more accurately as focusing exclusively on Innovative Medical's fundamentals will not take into account other important factors: Innovative Medical Cash |
|
Innovative Medical Total Value Analysis
Innovative Medical Management is presently estimated to have takeover price of 3.98 B with market capitalization of 4.33 B, debt of 30.17 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Innovative Medical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.98 B | 4.33 B | 30.17 M |
Innovative Medical Investor Information
About 41.0% of the company shares are owned by insiders or employees . The book value of Innovative Medical was presently reported as 4.18. The company recorded a loss per share of 0.11. Innovative Medical last dividend was issued on the 25th of June 2018. The entity had 20:10 split on the 6th of May 2011. Innovative Medical Management is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.Innovative Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Innovative Medical has an asset utilization ratio of 35.31 percent. This suggests that the Company is making USD0.35 for each dollar of assets. An increasing asset utilization means that Innovative Medical Management is more efficient with each dollar of assets it utilizes for everyday operations.Innovative Medical Ownership Allocation
Innovative Medical Management has a total of 441.28 Million outstanding shares. Innovative Medical secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Innovative Medical Profitability Analysis
The company reported the revenue of 805.59 M. Net Loss for the year was (34.29 M) with profit before overhead, payroll, taxes, and interest of 74.08 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Innovative Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Innovative Medical and how it compares across the competition.
About Innovative Medical Valuation
The stock valuation mechanism determines Innovative Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Innovative Medical. We calculate exposure to Innovative Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Innovative Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 83 M | 120.8 M |
Complementary Tools for Innovative Stock analysis
When running Innovative Medical's price analysis, check to measure Innovative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovative Medical is operating at the current time. Most of Innovative Medical's value examination focuses on studying past and present price action to predict the probability of Innovative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovative Medical's price. Additionally, you may evaluate how the addition of Innovative Medical to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |